Table 6.
Comparison of patient characteristics based on success rates within the RM group
| Complete, N = 94 | High, N = 54 | Moderate, N = 9 | Low, N = 12 | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sex (female) | n (%) | 45 (48%) | 30 (56%) | 4 (44%) | 7 (58%) | 0.78 | ||||
| Age (years) | Median [IQR] | 82.7 [75.7, 88.6] | 81.7 [78.9, 87.0] | 81.1 [76.3, 90.0] | 79.0 [72.9, 85.2] | 0.65 | ||||
| CFS | 0.36 | |||||||||
| Fit (CFS 1-3) | n (%) | 14 (15%) | 5 (9.3%) | 0 (0%) | 0 (0%) | |||||
| Mild to moderate (CFS 4-6) | n (%) | 38 (40%) | 29 (54%) | 5 (56%) | 4 (33%) | |||||
| Severe (CFS 7-9) | n (%) | 42 (45%) | 20 (37%) | 4 (44%) | 8 (67%) | |||||
| Frailty Index | Median [IQR] | 0.3 [0.3, 0.4] | 0.4 [0.2, 0.4] | 0.4 [0.3, 0.5] | 0.3 [0.3, 0.4] | 0.53 | ||||
| Multimorbidity | Median [IQR] | 4.0 [3.0, 6.0] | 4.0 [3.0, 6.0] | 5.0 [4.0, 7.0] | 4.0 [3.0, 5.0] | 0.25 | ||||
| Nr. of medications prior to admission | Median [IQR] | 10.0 [7.0, 13.0] | 11.5 [6.0, 14.0] | 15.0 [14.0, 17.0] | 12.5 [9.5, 16.0] | 0.02 | ||||
| EuroQol 5D | Median [IQR] | 0.4 [0.2, 0.6] | 0.4 [0.1, 0.6] | 0.1 [0.1, 0.4] | 0.6 [0.3, 0.7] | 0.23 | ||||
| Psychological well-being | Median [IQR] | 76.0 [60.0, 88.0] | 76.0 [56.0, 84.0] | 68.0 [52.0, 84.0] | 80.0 [57.0, 96.0] | 0.54 | ||||
| (i)ADL before admission | Median [IQR] | 24.0 [18.0, 31.0] | 24.0 [18.0, 30.0] | 27.0 [21.0, 35.0] | 24.0 [23.0, 26.0] | 0.78 | ||||
| (i)ADL at admission | Median [IQR] | 37.0 [32.0, 39.0] | 37.0 [33.3, 39.0] | 37.0 [32.0, 38.0] | 32.5 [27.8, 37.8] | 0.51 | ||||
| Treatment focus | 0.80 | |||||||||
| Curative | n (%) | 21 (22%) | 7 (13%) | 1 (11%) | 3 (25%) | |||||
| Recovery-oriented care | n (%) | 68 (72%) | 43 (83%) | 8 (89%) | 9 (75%) | |||||
| Symptom-oriented care | n (%) | 5 (5.3%) | 2 (3.8%) | 0 (0%) | 0 (0%) | |||||
| Length of stay (days) | Median [IQR] | 8.0 [5.0, 11.0] | 10.5 [7.3, 15.8] | 12.0 [4.0, 14.0] | 9.0 [6.5, 11.3] | 0.04 | ||||
| Deceased during admission | n (%) | 2 (2.2%) | 0 (0%) | 1 (11%) | 2 (17%) | 0.01 | ||||
| Men, N = 49 | Women, N = 45 | Men, N = 24 | Women, N = 30 | Men, N = 5 | Women, N = 4 | Men, N = 5 | Women, N = 7 | |||
| GSmax at baseline (kPa) | Median [IQR] | 50 [39, 61] | 36 [26, 48] | 51 [39, 59] | 34 [26, 44] | 50 [45, 54] | 33 [30, 38] | 35 [23, 38] | 27 [20, 29] |
M: 0.16 W: 0.30 |
| FR at baseline (s) | Median [IQR] | 24 [18, 32] | 22 [15, 37] | 24 [18, 27] | 18 [12, 26] | 13 [12, 14] | 11 [11, 11] | NA | NA |
M: 0.12 W: 0.08 |
| GW at baseline (kPa*s) | Median [IQR] | 855 [614, 1172] | 567 [330, 1169] | 963 [618, 1072] | 419 [310, 753] | 731 [647, 815] | 289 [289, 289] | NA | NA |
M: 0.72 W: 0.27 |
Complete group: patients having 100% successful tests. High group: patients having 50%-99 successful tests. Moderate group: patients having 25%-49% successful tests. Low group: patients having 25% or less successful tests (no participants in this group)
CFS (Clinical Frailty Scale): 1-9, lower is better. Frailty index: 0-1, lower is better. Multimorbidity: 0-17, lower is better. EuroQol 5D: -0.4-1, higher is better. (i)ADL: (instrumental) Activities of Daily Living, 5-40, higher scores indicate more dependency. Psychological wellbeing: 0-100, higher is better. GSmax: maximal Grip Strength, higher is better. FR: Fatigue resistance, higher is better. GW: Grip Work, higher is better